PRESS RELEASE | March 28, 2017
Marcum Bernstein & Pinchuk LLP ("MarcumBP"), a top-ranked provider of SEC audit, accounting and consulting services to Chinese companies listed in the U.S. capital markets, was a featured presenter at the inaugural China healthcare investor conference presented by Maxim Group and Haitong Securities in Shanghai on March 6 and 7, 2017.
The debut Healthcare Investor and Partnering Conference brought together executives of U.S. healthcare companies, Chinese institutional investors, and Chinese healthcare enterprises for two days of company presentations and networking. As a lead presenter, MarcumBP brought to the conference highly specialized experience in regulatory, operational, financial, clinical, assurance and tax services to the healthcare industry. Drew Bernstein, co-managing partner, addressed the conference on the subject of "U.S.-China Healthcare Partnerships: M&A, Partnering, and Sinofication.
"The Chinese healthcare market is on the verge of profound disruptions, driven by the intersection of demographics, income distribution, disease states, and technology," Mr. Bernstein said. "China is poised to become the largest pharmaceutical market in the world, with healthcare spending projected to reach $1.49 trillion by 2020 and an over-65 population of 348 million by 2050. These changes will have significant implications for cross-border M&A, partnership structures, and 'Sinofication' for multi-nationals looking to access the China market."
MarcumBP's dedicated China Healthcare Team provides assurance, tax, risk management, and cross-border M&A support to both Chinese and U.S. companies. An affiliate of Marcum LLP, one of the largest independent accounting and advisory firms in the United States, Marcum BP also has access to a deep bench of expertise in the Firm's national Healthcare Practice Group, including all aspects of corporate tax services, regulatory compliance and operational best practices.
About Marcum Bernstein & Pinchuk LLP
Marcum Bernstein & Pinchuk LLP ("MarcumBP") is a top-ranked provider of SEC audit, accounting, and consulting services to Chinese companies listed in the U.S. capital markets. The firm is based in New York City and has five offices in China. A member of the Marcum Group and an affiliate of Marcum LLP, a leading U.S. accounting and advisory firm, MBP provides financial due diligence and forensic accounting services to overseas investors and companies seeking to invest in China, and Chinese companies and individuals pursuing overseas expansion. Services include mergers and acquisitions, global tax, capital verification, financial due diligence, real estate, and EB-5 investment services.
About Marcum LLP
Marcum LLP is one of the largest independent public accounting and advisory services firms in the nation, with offices in major business markets throughout the U.S., as well as Grand Cayman, China and Ireland. Headquartered in New York City, Marcum provides a full spectrum of traditional tax, accounting and assurance services; advisory, valuation and litigation support; and an extensive range of specialty and niche industry practices. The Firm serves both privately held and publicly traded companies, as well as high net worth individuals, private equity funds and hedge funds, with a focus on middle-market companies and closely held family businesses. Marcum is a member of the Marcum Group, an organization providing a comprehensive array of professional services.